Barely Significant
← all excerpts

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

Ther Adv Respir Dis · 2020 · PMC7268123 · PMID 32482128

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
The number of patients experiencing exacerbations decreased only during treatment with mepolizumab, and in a statistically highly significant manner [odds ratio, 0.019; 95% confidence interval (CI), 0.001–0.320; hazard ratio p < 0.0001].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.